Zibotentan
In Stock•Starting at $37 for 1 mg•Purity ≥ 98%
| CAS No. | 186497-07-4 |
|---|---|
| MDL No. | MFCD09955343 |
| MF | C19H16N6O4S |
| MW | 424.40 |
| InChI Key | FJHHZXWJVIEFGJ-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 98% | $37 | In Stock | |
| 5 mg | 98% | $102 | In Stock | |
| 10 mg | 98% | $164 | In Stock | |
| 25 mg | 98% | $309 | In Stock | |
| 50 mg | 98% | $523 | In Stock |
Product Information
Zibotentan is a pyridinesulfonamide with a benzene ring substituted at positions 1 and 4 by 3-[(3-methoxy-5-methylpyrazin-2-yl)sulfamoyl]pyridin-2-yl and 1,3,4-oxadiazol-2-yl groups, respectively. It is an endothelin A receptor antagonist with potential antineoplastic activity. It functions as an endothelin A receptor antagonist, antineoplastic agent, and antihypertensive agent. It is classified as a phenylpyridine, pyrazine, aromatic ether, pyridinesulfonamide, benzene, and 1,3,4-oxadiazole.
| CAS No. | 186497-07-4 |
|---|---|
| Product Name | Zibotentan |
Biological Targets
EDNRA
Associated Conditions
prostate cancer·non-small cell lung carcinoma·prostate adenocarcinoma·ovarian cancer·breast cancer·
* The information provided here is compiled from public sources and is for reference only.